Patricia Kropf

Functional genomic landscape of acute myeloid leukaemia

Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly et al. · Nature · 2018 · 1.4K citations · Full text

Hematological Malignancy, Chromatin, Functional Genomics +7

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud et al. · Journal of the National Comprehensive Cancer Network · 2017 · 651 citations · Full text

Hematological Malignancy, Version 3.2017, Oncology +14

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial

Hagop M. Kantarjian, Gail J. Roboz, Patricia Kropf et al. · The Lancet Oncology · 2017 · 152 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +11

Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial

Guillermo Garcia‐Manero, Gail J. Roboz, Katherine Walsh et al. · The Lancet Haematology · 2019 · 91 citations · Full text

Hematological Malignancy, Medicine, Hematology +7

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017

Arnel Pallera, Jessica K. Altman, Ellin Berman et al. · Journal of the National Comprehensive Cancer Network · 2016 · 85 citations · Full text

Fertility, Mixed-phenotype Acute Leukemia, Reproductive Health +16